Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

All four treatments for early rheumatoid arthritis had similar safety profiles.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

OR-101 shows promise for treating alopecia areata by improving hair growth.

BST2 protein and certain T cells increase in early alopecia areata.

A woman's complete hair loss condition improved after recovering from COVID-19.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

OXTR agonists may promote hair growth and be effective for treating hair loss.

taVNS reduces vitiligo symptoms in mice.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

DNA markers can predict physical traits for forensic use, but there are ethical and technical challenges.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Exosomes can help promote hair growth and may treat hair loss.

Topical tofacitinib is effective and safe for treating alopecia areata.